Small Intestinal Bacterial Overgrowth (SIBO) occurs when bacteria that normally inhabit the colon proliferate in the small intestine, disrupting digestion and causing symptoms such as bloating, gas, abdominal pain, diarrhea or constipation, and nutrient deficiencies. Effective management combines accurate diagnosis, targeted antimicrobial strategies, dietary modulation, and measures that support gut motility and microbial balance.

Diagnosis typically begins with clinical assessment and breath testing (hydrogen and methane) to detect abnormal fermentation in the small intestine. Complementary data from DNA-based stool profiling can provide context about overall microbial community structure and potential contributors to dysbiosis; for more on noninvasive testing options, consider resources describing DNA-based stool testing.

Treatment is individualized. Antimicrobial therapy—either targeted antibiotics or validated herbal antimicrobials—aims to reduce bacterial load in the small intestine. Choice of agent should be informed by breath test results (e.g., hydrogen- versus methane-dominant SIBO) and clinical factors. For methane-dominant presentations, treatment approaches differ because archaea, not typical bacteria, often produce methane and may respond to specific combination regimens.

Dietary strategies serve two purposes: symptom relief during treatment and reducing fermentable substrates that can encourage regrowth. Low-fermentable carbohydrate approaches (e.g., low-FODMAP or specific carbohydrate modifications) can reduce bloating and gas but are generally part of a broader plan rather than a sole cure. Practical guidance on meal choices during acute gut infections and recovery can be found in general food-avoidance resources such as advice about avoiding foods with a stomach bug.

Restoring motility and addressing underlying drivers is critical to prevent recurrence. Conditions like connective tissue disorders, diabetic autonomic neuropathy, structural abnormalities, or medications that slow gut transit can predispose to SIBO. Prokinetic agents, where appropriate, and lifestyle measures that support regular bowel movements (adequate hydration, scheduled meals, and physical activity) help reduce stagnation and reinoculation of the small intestine.

Probiotics and prebiotics are used selectively. Some strains can support recovery by competing with undesirable microbes or by enhancing mucosal barrier function, while other products may transiently worsen symptoms in sensitive individuals. Microbiome profiling and symptom monitoring can guide which supplements, if any, are appropriate. For a discussion of gut flora symptoms and related patterns, see information on symptoms of unhealthy gut flora and the overview at What are the symptoms of an unhealthy gut flora.

Follow-up testing—typically repeat breath testing and clinical reassessment—is important to confirm eradication and to guide maintenance strategies. Long-term success often depends on addressing predisposing factors, using targeted microbial interventions, and applying dietary and lifestyle supports tailored to the individual.

For a focused discussion of treatment sequencing, practical symptom tracking, and when to involve specialist care, a detailed resource that outlines clinical and lifestyle approaches is available in this detailed guide on getting rid of SIBO. Evidence-based recovery is typically gradual and requires coordinated diagnostic data, a personalized plan, and ongoing monitoring rather than a single universal remedy.